The Australian Pesticides and Veterinary Medicines Authority (APVMA) has release a final report with recommendations regarding nanotechnology regulation according to a July 13, 2015 news item on Nanowerk (Note: A link has been removed),

Publication of the report Nanotechnologies for pesticides and veterinary medicines: regulatory considerations—final report (July 2015) marks the culmination of four years of Australian Pesticides and Veterinary Medicines Authority (APVMA)-led research, consultation and collaboration.

The report considers the benefits and challenges of regulating nanotechnology for use in agriculture and animal husbandry, as advances in nanoscale science, engineering and technology pave the way for developing novel applications, devices and systems.

The report aims to inform and stimulate discussion about emerging nanotechnology and highlights the key regulatory considerations for agvet chemical nanomaterials based on the current state of knowledge.

It systematically explores the opportunities and risks of these substances in Australian agriculture and animal husbandry and reviews the published work relevant to the registration of nanoscale agvet chemicals.

A July 6, 2015 APVMA press release, which originated the news item, provides a brief history of the deliberations which led to the report and a brief description of the actions which will follow its publication,

In October 2014, the APVMA hosted a symposium on nanotechnology regulation, seeking national and international input from industry, scientists, regulators and the broader community on developing a regulatory framework for nanotechnologies in Australian agriculture and animal husbandry. Discussion was based on the APVMA draft report Regulatory considerations for nanopesticides and veterinary medicines (October 2014), the first of its kind to be made available for public discussion. Input subsequently received was considered in finalising the report.

Next steps

The APVMA will now use the report to finalise the regulatory approach for nanotechnology products, including:

building capability and expertise so new products can be evaluated effectively
analysing the data requirements
enhancing the existing regulatory framework if required as knowledge evolves
continuing to engage with the international scientific community so that the latest

You can find the final report here.